Evidence map›Paper›PMID 30827115›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2019

Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery.

Brian E Oeffinger, Purva Vaidya, Iman Ayaz, Rawan Shraim, John R Eisenbrey, Margaret A Wheatley

Open access · greenAbstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brian E OeffingerSchool of Biomedical Engineering Science and Health Systems , Drexel University , Philadelphia , Pennsylvania 19104 , United States.
Purva VaidyaSchool of Biomedical Engineering Science and Health Systems , Drexel University , Philadelphia , Pennsylvania 19104 , United States.
Iman AyazSchool of Biomedical Engineering Science and Health Systems , Drexel University , Philadelphia , Pennsylvania 19104 , United States.
Rawan ShraimSchool of Biomedical Engineering Science and Health Systems , Drexel University , Philadelphia , Pennsylvania 19104 , United States.
John R EisenbreyDepartment of Radiology , Thomas Jefferson University , Philadelphia , Pennsylvania 19107 , United States.
Margaret A WheatleySchool of Biomedical Engineering Science and Health Systems , Drexel University , Philadelphia , Pennsylvania 19104 , United States.ORCID 0000-0001-6917-8972
Drexel University · USThomas Jefferson University · US

Funding

Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor HypoxiaR01EB026881 · NIBIB · THOMAS JEFFERSON UNIVERSITY · PI EISENBREY, JOHN, WHEATLEY, MARGARET A. · 2018 to 2021
$2.5M
Streamlining Path to Success for Design of Life Saving Devices: An Integrated EduR25EB013038 · NIBIB · DREXEL UNIVERSITY · PI BARBEE, KENNETH A · 2012 to 2016
$208k
NIBIB NIH HHS R01 EB026881NIBIB NIH HHS R25 EB013038
6 · The paper itself

Abstract

Ultrasound contrast agents consist of stabilized microbubbles. We are developing a surfactant-stabilized microbubble platform with a shell composed of Span 60 (Sorbitan monostearate) and an emulsifying agent, water-soluble vitamin E (α-tocopheryl poly(ethylene glycol) succinate, abbreviated as TPGS), named SE61. The microbubbles act both as an imaging agent and a vehicle for delivering oxygen to hypoxic areas in tumors. For clinical use, it is important that a platform be stable under storage at room temperature. To accomplish this, a majority of biologicals are prepared as freeze-dried powders, which also eliminates the necessity of a cold chain. The interfaces among the surfactants, gas, and liquids are subject to disruption in both the freezing and drying phases. Using thermocouples to monitor temperature profiles, differential scanning calorimetry to determine the phase transitions, and acoustic properties to gauge the degree of microbubble disruption, the effects of the freezing rate and the addition of different concentrations of lyoprotectants were determined. Slower cooling rates achieved by freezing the samples in a -20 °C bath were found to be reproducible and produce contrast agents with acceptable acoustical properties. The ionic strength of the solutions and the concentration of the lyoprotectant determined the glass-transition temperature (

Indexed as

Freeze DryingMicrobubblesContrast MediaDrug CarriersDrug StabilityEmulsifying AgentsHexosesOxygenPhase TransitionVitamin EContrast MediaDrug CarriersEmulsifying AgentsHexosesOxygensorbitan monostearatetocophersolanVitamin E

Identifiers

PMID30827115
PMCPMC7041305
OpenAlexW2919057047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.